Cardiovascular Nanotechnology

Nanotechnology is a branch of science concerned with materials on the nanoscale. Nanomaterials are distinguished by their mechanical, electrical, chemical, and optical properties. Understanding the properties of nanomaterials allows us to use them in research, diagnosis, and treatment of heart, lung, blood, and sleep disorders. Nanotechnology will provide novel treatments for a wide range of ailments, including cardiovascular disorders. Ischemic heart disease is one of the most common illnesses in various parts of the world. Each year, the death rate from cardiac disease rises dramatically. Despite increased treatment for ischemia and infarct heart disease, it primarily results in heart failure.

The inability to administer medication to the damaged area, the lack of stem cell implantation, tissue regeneration, and extra damage in ischemic tissue all contribute to death. The application of nanotechnology has yielded promising outcomes in the therapeutic environment. Several nanotechnology-based treatments for ischemic heart disease are being developed, including simple and modified drug/stem cell delivery systems based on magnetic, antibody-linked, and mesoporous silica nanoparticles.

Nanoparticle vehicles have evolved as a method for delivering therapeutic medicines to portions of the wounded or dysfunctional vascular wall, particularly arterial segments at risk of restenosis following percutaneous coronary procedures. This method of infusion allows for the administration of medicines to specific locations of vascular malfunction or injury. A combination of known/approved ultrasonography contrast vascular imaging agents complex with therapeutic agents is one of the technology's components. A variety of therapeutic medicines have been investigated for integration into the nano-particle delivery vehicle and efficacy in preventing re-stenosis.